LAMPERTICO, PIETRO
LAMPERTICO, PIETRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Comprehensive investigation of platelet function in patients with cirrhosis
2024 A. Lecchi, G. Tosetti, C. Ghali, S. La Marca, M. Clerici, L. Padovan, E.A. Femia, M. Primignani, V. La Mura, P. Lampertico, F. Peyvandi, A. Tripodi
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis
2024 A. Tripodi, M. Primignani, R. D'Ambrosio, G. Tosetti, V. La Mura, P. Lampertico, F. Peyvandi
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
2024 L. A Kondili, G. Brancaccio, M. Elena Tosti, B. Coco, M. Giovanna Quaranta, V. Messina, A. Ciancio, F. Morisco, V. Cossiga, E. Claar, V. Rosato, M. Ciarallo, I. Cacciola, F. Romana Ponziani, L. Cerrito, R. Coppola, F. Longobardi, E. Biliotti, A. Rianda, F. Barbaro, N. Coppola, M. Stanzione, F. Barchiesi, S. Fagiuoli, M. Viganò, M. Massari, F. Paolo Russo, A. Ferrarese, D. Laccabue, V. Di Marco, P. Blanc, A. Marrone, G. Morsica, A. Federico, D. Ieluzzi, A. Rocco, F. Giuseppe Foschi, A. Soria, I. Maida, L. Chessa, M. Milella, E. Rosselli Del Turco, S. Madonia, L. Chemello, I. Gentile, P. Toniutto, M. Bassetti, L. Surace, L. Baiocchi, A. Pellicelli, A. De Santis, M. Puoti, E. Degasperi, G. Anna Niro, A. Linda Zignego, A. Craxi, G. Raimondo, T. Antonia Santantonio, M. Rossana Brunetto, G. Battista Gaeta, A. Aghemo, C. Baiguera, P.M. Battezzati, S. Battistella, M. Grazia Bavetta, C. Bertoni, C. Boni, P. Brambilla, A. Bray, F. Briano, E. Carmenini, F. Castelli, L. Cavalletto, F. Cerini, L. Chidichimo, E. Colella, G. Cologni, S. Como, R. Corsini, C. Costa, R. Cotugno, S. Cretella, F. De Angelis, P. De Leo, G. Di Perri, E. Falbo, L. Ferrigno, E. Fornasiere, D. Francisci, P. Gatti, P. Lampertico, I. Lenci, A. Licata, I. Maida, A. Marzano, A. Mastroianni, C. Mazzaro, M. Monti, G. Nardone, L. Ambra Nicolini, N. Passigato, M. Bruna Pasticci, P. Pierotti, B. Pinchera, T. Pollicino, C. Porcu, G. Quartini, G. Rancatore, M. Romeo, M. Grazia Rumi, A. Saracino, O. Schioppa, I. Serio, R. Soffredini, X. Tata, M. Tizzani, M. Tonnini, C. Torti, D. Valenti, S. Zaltron, A. Zoncada
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
2024 L. Shekhtman, S.J. Cotler, E. Degasperi, M.P. Anolli, S.C. Uceda Renteria, D. Sambarino, M. Borghi, R. Perbellini, F. Facchetti, F. Ceriotti, P. Lampertico, H. Dahari
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine
2024 L.C. Morlacchi, G. Alicandro, S. Uceda Renteria, N. Zignani, G. Giacomel, V. Rossetti, M. Sagasta, G. Citterio, A. Lombardi, C. Dibenedetto, B. Antonelli, L. Rosso, P. Lampertico, F. Ceriotti, F. Blasi, M.F. Donato
Stesura di progetto internazionale di screening, vaccinazione e cura contro l'epatite C - Multi-country Viral Hepatitis COMmunity Screening, Vaccination, and Care (VH-COMSAVAC): Project outline
2023 A.M. Pezzullo, C.A. Picchio, L. Villani, D. Pascucci, R. Pastorino, M. Di Pumpo, A. Taha, L. Van Selm, D. Boudou, D. Fortin, G. Kalamitsis, M. Colombo, G. Colucci, P. Lampertico, A.G. De Belvis, C. La Vecchia, S. Boccia, J.V. Lazarus
HDV RNA Assays: Performance characteristics, clinical utility and challenges
2023 H. Wedemeyer, M. Leus, T. R Battersby, J. Glenn, E. Gordien, S. Kamili, H. Kapoor, H. H Kessler, O. Lenz, M. Lütgehetmann, T. Mixson-Hayden, C. O Simon, M. Thomson, G. Westman, V. Miller, N. Terrault, P. Lampertico
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro
2023 M. Rossi, A. Vecchi, C. Tiezzi, V. Barili, P. Fisicaro, A. Penna, I. Montali, S. Daffis, S. Fletcher, A. Gaggar, J. Medley, M. Graupe, L. Lad, A. Loglio, R. Soffredini, M. Borghi, T. Pollicino, C. Musolino, A. Alfieri, F. Brillo, D. Laccabue, M. Massari, C. Boarini, G. Abbati, G. Pedrazzi, G. Missale, P. Lampertico, C. Ferrari, C. Boni
Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosis
2023 A. Costantino, A. Piagnani, R. Caccia, A. Sorge, M. Maggioni, R. Perbellini, F. Donato, R. D'Ambrosio, N.P. O Sed, L. Valenti, D. Prati, M. Vecchi, P. Lampertico, M. Fraquelli
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B
2023 I. Montali, C. Ceccatelli Berti, M. Morselli, G. Acerbi, V. Barili, G. Pedrazzi, B. Montanini, C. Boni, A. Alfieri, M. Pesci, A. Loglio, E. Degasperi, M. Borghi, R. Perbellini, A. Penna, D. Laccabue, M. Rossi, A. Vecchi, C. Tiezzi, V. Reverberi, C. Boarini, G. Abbati, M. Massari, P. Lampertico, G. Missale, C. Ferrari, P. Fisicaro
Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV?
2023 G. Tosetti, E. Degasperi, E. Farina, M. Primignani, P. Lampertico
Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology
2023 D. Huang, A. Singal, F. Kanwal, P. Lampertico, M. Buti, C. Sirlin, M. Nguyen, R. Loomba
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years
2023 E. Farina, A. Loglio, G. Tosetti, E. Degasperi, M. Viganò, C. Gentile, S. Monico, R. Perbellini, M. Borghi, F. Facchetti, S. Uceda Renteria, F. Ceriotti, F. Cerini, M. Primignani, P. Lampertico
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics
2023 M.P. Anolli, E. Degasperi, L. Allweiss, A. Sangiovanni, M. Maggioni, C. Scholtes, V. Oberhardt, C. Neumann-Haefelin, M. Dandri, F. Zoulim, P. Lampertico
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
2023 P. Lampertico, E. Degasperi, L. Sandmann, H. Wedemeyer, C. Yurdaydin, D. Roulot, F. Zoulim, F.A. Caruntu, H. Kefalakes, J. Lucifora, K. Agarwal, L. Castera, M. Buti, M. Rizzetto, M. Cornberg, M. Dandri, M. Brunetto, N. Reau, R. Gish, S. Hamid, S. Aleman, S. Urban, T. Asselah, T. Berg, V. de Ledinghen
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
2023 M.G. Ghany, M. Buti, P. Lampertico, H.M. Lee
Hepatitis Delta: Ready for primetime?
2023 B. Maasoumy, P. Lampertico
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review
2023 E. Degasperi, M.P. Anolli, P. Lampertico
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes
2023 M. G Peters, M. Yuen, N. Terrault, J. Fry, P. Lampertico, E. Gane, C. Hwang, L. M Stamm, M. Leus, M. K Maini, P. Mendez, I. Lonjon-Domanec, T. Berg, S. Wang, P. Mishra, E. Donaldson, S. Buchholz, V. Miller, O. Lenz
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals
2023 S. Pelusi, C. Bianco, M. Colombo, G. Cologni, P. Del Poggio, N. Pugliese, D. Prati, M. Graciella Pigozzi, R. D'Ambrosio, P. Lampertico, S. Fagiuoli, L. Valenti